Click it and Unblock the Notifications
Latest Updates
-
Paneer Lababdar Recipe: Indulge in Restaurant Style Rich Gravy -
Meet Prachi Nigam: Former Board Topper Scores 91.2% In Class 12, Once Trolled For Facial Hair On Social Media -
The Emerging Aroma Of Home: How Living Rooms Are Evolving Past Clean Linen And Fresh Cotton Fragrances -
Hacks 101: 8 Simple Tricks To Stay Sweat-Proof All Day -
Chilli Potato Recipe: A Crispy Indo Chinese Twist -
India’s Nutrition Paradox: Why ‘Healthy Eating’ Isn’t Fixing Deficiencies -
Can Drinking Less Water Increase Uric Acid and Trigger Kidney Stones? Expert Shares Warning Signs -
Humuss Sunscreen & Night Cream Review: My Honest Take On These Vegan Skincare Must-Haves For Summer -
Remembering Asha Bhosle Through Her Favourite Sol Kadhi Recipe, A Refreshing Summer Drink To Try At Home -
A Child Is Dead After Eating Pani-Puri In Jharkhand — And It's A Warning For Every Parent This Summer
Diabetes Drug May Cut Heart, Kidney Disease Risk
A drug that lowers blood sugar levels for people with Type 2 diabetes may also significantly help reduce the risk of both cardiovascular and kidney disease, researchers claimed.
A drug that lowers blood sugar levels for people with Type 2 diabetes may also significantly help reduce the risk of both cardiovascular and kidney disease, researchers claimed.
Type 2 diabetes, which affects around 450 million people worldwide, also increases the risks of stroke and heart attack.
The findings, published in the New England Journal of Medicine, showed that the drug -- canagliflozin -- reduced the overall risk of cardiovascular disease by 14 per cent and reduced the risk of heart failure hospitalisation by 33 per cent.
It was also shown to have a significant impact on the progression of renal disease, as the patients were 40 per cent less likely to suffer serious kidney decline, the researchers said in the paper published in the New England Journal of Medicine.
"Coronary heart disease is the biggest killer by far for people with Type 2 diabetes. Our findings suggest that not only does canagliflozin significantly reduce the risk of heart disease, it also has many other benefits too. We found it also reduced blood pressure and led to weight loss," said Bruce Neal, Professor at The George Institute for Global Health in New South Wales, Australia.
Canagliflozin, known as a SGLT2 inhibitor, is a relatively new type of drug that works by blocking the body's reabsorption of sugar or glucose.
This results in more glucose being released in urine and a drop in glucose levels. Most other diabetes drugs work by managing insulin levels.
"This really is a game changer in the treatment of Type 2 diabetes. It not only reduces the risk of heart disease, it also provides real protection against kidney decline which affects many people with diabetes," added Vlado Perkovic, Professor and Executive Director at The George Institute for Global Health.
For the study, the team analysed more than 10,000 patients in 30 countries.
With Inputs From IANS
Disclaimer: The information provided in this article is for general informational and educational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or a qualified healthcare provider with any questions you may have regarding a medical condition.
Continue with Google